BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Agios Pharmaceuticals 

38 Sidney Street
2nd Floor
Cambridge  Massachusetts  02139-4169  U.S.A.
Phone: 617-649-8600 Fax: n/a


SEARCH JOBS










 Company News
Agios Pharmaceuticals (AGIO) Announces Closing Of Public Offering And Full Exercise Of Over-Allotment Option 12/17/2014 7:39:09 AM
Agios Pharmaceuticals (AGIO) Announces Pricing Of $220 Million Public Offering Of Common Stock 12/11/2014 7:30:29 AM
Agios Pharmaceuticals (AGIO) Announces Proposed Offering Of Common Stock 12/10/2014 6:57:44 AM
Agios Pharmaceuticals (AGIO) Appoints Kaye Foster-Cheek To Its Board Of Directors 12/10/2014 6:56:50 AM
Agios Pharmaceuticals (AGIO) Reports Positive Phase 1 Data In Healthy Volunteers For AG-348, A First-In-Class Investigational Medicine That Targets The Underlying Cause Of Pyruvate Kinase (PK) Deficiency 12/9/2014 10:17:24 AM
Agios Pharmaceuticals (AGIO) Announces Celgene (CELG) Decision To Extend Discovery Phase Of Global Strategic Collaboration To April 2016 12/8/2014 8:34:12 AM
Agios Pharmaceuticals (AGIO) Announces New Data From Ongoing Phase 1 Trial Of AG-221 Showing Robust Clinical Activity In Patients With Advanced Hematologic Malignancies 12/8/2014 7:31:58 AM
Agios Pharmaceuticals (AGIO) Announces Early Phase 1 Data Showing Clinical Activity Of AG-120 As A Single Agent In Advanced Acute Myeloid Leukemia (AML) 11/18/2014 4:43:48 PM
Citi: Agios Pharmaceuticals (AGIO)’s Experimental Cancer Drug Could Provide Major Upside 11/10/2014 12:58:54 PM
Agios Pharmaceuticals (AGIO) Reports Third Quarter 2014 Financial Results 11/7/2014 8:47:52 AM
12345678910